India Brucellosis Market Research Report By species (Brucella suis, B

India Brucellosis Market Overview

As per MRFR analysis, the India Brucellosis Market Size was estimated at 14.23 (USD Million) in 2023.The India Brucellosis Market is expected to grow from 20.5(USD Million) in 2024 to 65.3 (USD Million) by 2035. The India Brucellosis Market CAGR (growth rate) is expected to be around 11.107% during the forecast period (2025 - 2035).

Key India Brucellosis Market Trends Highlighted

The growing awareness of zoonotic diseases and more government activities are driving notable developments in the India brucellosis market. Understanding the effects of brucellosis on both animal and human populations, the Indian government has improved livestock health management.

Enhancing disease control and prevention efforts is the goal of initiatives like the Department of Animal Husbandry and Dairying's immunization programs and awareness campaigns. Additionally, the need for efficient treatment options and diagnostic testing has increased due to the rising prevalence of brucellosis in both human and animal populations.

There are several opportunities in the India brucellosis market, especially for regional companies and individuals who specialize in veterinary healthcare goods and services. The market for cutting-edge diagnostics and vaccines is expanding, as are farmer-focused training initiatives that support optimal livestock management techniques.

Furthermore, the growth of public-private partnerships can aid in the creation of cutting-edge brucellosis management methods. Recent patterns demonstrate the growing use of sophisticated testing approaches in diagnostics, including polymerase chain reaction (PCR) and serological testing.

These developments make it possible to identify brucellosis more quickly and accurately, which aids in prompt intervention. Additionally, there is a discernible trend toward the use of digital technologies into systems for managing and monitoring livestock health.

In addition to enhancing disease tracking, this trend helps inform farmers and livestock owners about the need of preserving animal health in order to stop the spread of zoonotic diseases. A collaborative effort to improve public safety and animal health is demonstrated by all of these developments, which point to a dynamic shift in the India brucellosis market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Brucellosis Market Drivers

Rising Incidence of Brucellosis in Livestock

The India Brucellosis Market is experiencing growth due to the rising incidence of brucellosis in livestock, notably cattle and goats. According to the Department of Animal Husbandry and Dairying in India, reports indicate that the prevalence of brucellosis in dairy cattle has been recorded as high as 20% in some states.

The Government of India has recognized this issue and is actively promoting vaccination programs to combat this disease, thereby leading to a significant market for brucellosis diagnostics and treatment solutions.

The growing awareness among farmers regarding the economic impacts of brucellosis on milk production and livestock health is enhancing demand for effective diagnostic tests and vaccines, which benefits the overall India Brucellosis Market.

Established organizations like the Indian Council of Agricultural Research are also collaborating on initiatives to mitigate brucellosis outbreaks, hence solidifying this as a critical driver for market growth.

Increased Government Initiatives and Funding

Government initiatives and funding aimed at controlling brucellosis are significant drivers for the India Brucellosis Market. Recent policies from the Ministry of Fisheries, Animal Husbandry and Dairying indicate the allocation of funds for the integrated National Animal Disease Control Programme aimed at eradicating brucellosis, which is expected to impact nearly 500 million livestock animals in India.

This policy is backed with an investment of approximately USD 1.65 billion for disease management and vaccination strategies. Such efforts not only strengthen domestic livestock health but also propel market demand for effective brucellosis-related products.

By enhancing public health and animal health simultaneously, organizations like the Food and Agriculture Organization are also promoting these initiatives to help control zoonotic diseases, thereby increasing market confidence in brucellosis diagnostics and therapeutic solutions.

Growing Public Awareness of Zoonotic Diseases

The growing public awareness of zoonotic diseases, including brucellosis, is fostering a significant shift in the India Brucellosis Market. As India faces an increased focus on food safety and animal health following various outbreaks, the public is becoming more informed about the risks associated with zoonotic diseases.

The Ministry of Health and Family Welfare has launched campaigns to educate both farmers and consumers about the transmission of diseases between animals and humans. This increased awareness is leading to a higher demand for diagnostic tools and preventive measures against brucellosis.

Research findings from established health organizations illustrate a steady increase in health-related concerns and a greater push towards safer livestock handling practices, which links directly to the rise in the market for brucellosis solutions.

India Brucellosis Market Segment Insights

Brucellosis Market species Insights

The India Brucellosis Market has shown substantial interest in the species segment, which encompasses various types of Brucella bacteria such as Brucella suis, B. abortus, and B. melitensis. Each species presents unique challenges and implications for both animal health and human safety in India.

Brucella suis, primarily associated with swine, has raised concerns particularly among pig farmers in specific regions, as it poses health risks to both livestock and humans. On the other hand, B. abortus is primarily associated with cattle and is a significant concern due to its impact on the dairy industry, leading to economic losses and affecting milk production, which is critical for rural economies in India.

B. melitensis is known for affecting sheep and goats, and its prevalence has implications for food safety and public health, particularly in pastoral communities where livestock is a primary source of livelihood. Understanding the dynamics of these species is crucial for implementing effective control measures.

The growing focus on livestock health and biosecurity in India, coupled with increased awareness among farmers and veterinarians, has fostered a conducive environment for addressing the burden posed by these bacteria.

The Government of India, alongside various agricultural and animal health organizations, has been proactive in disease surveillance and management, aiming to reduce the incidence of brucellosis through educational programs, vaccination, and improved diagnostic tools.

This strategic focus not only aims at safeguarding animal health but also strives to protect public health, highlighting the intertwined nature of agriculture and healthcare in India.

Given the significance of these Brucella species, ongoing research and interventions are expected to evolve, aiming to bolster the resilience of the livestock sector and minimize the risk of zoonotic transmission, which is crucial for the health of the population.

As the demand for livestock products continues to rise, addressing the challenges posed by these specific species will be pivotal in ensuring sustainable growth and stability within the broader context of the India Brucellosis Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Brucellosis Market Key Players and Competitive Insights

The India Brucellosis Market has been experiencing growth in response to the increasing prevalence of brucellosis among livestock, as well as a heightened awareness regarding animal health and public safety.

As a zoonotic disease, brucellosis poses significant economic implications for the livestock industry, motivating various stakeholders, including pharmaceutical companies and veterinarians, to actively engage in the market.

This environment has fostered a competitive landscape where several companies strive to provide effective diagnostic tools, vaccines, and treatment options aimed at controlling and eradicating brucellosis within the agricultural sector.

The players in this market vary from established pharmaceutical firms to emerging biotech companies, each bringing their strengths and innovations whilst vying for market share.

Allied Veterinary Products holds a significant position within the India Brucellosis Market, courtesy of its robust portfolio that emphasizes high-quality veterinary medicines and vaccines designed specifically for infectious diseases. The company is recognized for its commitment to research and development, often being at the forefront of innovation in veterinary medicine within India.

Its strengths lie in a deep understanding of local agricultural practices, enabling tailored products that cater specifically to the needs of livestock farmers. Additionally, they maintain strong partnerships with veterinary practitioners, facilitating increased product penetration in rural areas.

The focus on customer education and support further amplifies Allied Veterinary Products’ market presence, making it a formidable competitor in the industry.

Biocon has established itself as a pivotal player in the Indian brucellosis market, offering a range of biopharmaceutical products with an emphasis on improving livestock health. The company is primarily known for its innovative vaccines and diagnostic products aimed at controlling brucellosis, thus ensuring safer animal husbandry practices.

Biocon has made significant strides in market presence due to its extensive research capabilities, expertise in biotechnology, and a strategic focus on addressing local health challenges. The company has engaged in various collaborations and partnerships with local agribusinesses and research institutions to enhance its product offerings and expand its reach.

Additionally, mergers and acquisitions have complemented its growth strategy, allowing Biocon to diversify its product portfolio while reinforcing its competitive edge in the brucellosis segment of the veterinary market in India.

Key Companies in the India Brucellosis Market Include:

• Allied Veterinary Products


• Biocon


• IDEXX Laboratories


• Neogen Corporation


• Vetoquinol


• Agrovet Market Animal Health


• Heska Corporation


• Merck Animal Health


• Hester Biosciences


• Indian Immunologicals


• Boehringer Ingelheim


• Ceva Santé Animale


• Virbac


• Bioniche Animal Health


• Zoetis

India Brucellosis Market Developments

The India Brucellosis Market is witnessing significant developments, with increasing awareness of animal health and the economic impact of brucellosis. Allied Veterinary Products, Hester Biosciences, and Zoetis are among the companies enhancing their research initiatives and product offerings to tackle this zoonotic disease.

In recent months, there has been a notable rise in public health campaigns initiated by the Indian government aimed at educating farmers about brucellosis and its control measures. Recent market valuations have shown a positive trend, largely due to the heightened investment in diagnostics and vaccines, particularly from companies like Biocon and Merck Animal Health, contributing to overall market growth.

Additionally, in March 2023, substantial investments were made in the production of improved diagnostic tests for brucellosis, highlighting the focus on innovative solutions. Mergers and acquisitions remain relatively stable in this sector, with an emphasis on collaboration for Research and Development in vaccine technologies.

The collective efforts of firms like Virbac, IDEXX Laboratories, and Boehringer Ingelheim are pivotal in addressing this public health challenge, enhancing the market's capacity to respond effectively to brucellosis outbreaks across India.

India Brucellosis Market Segmentation Insights

Brucellosis Market species Outlook

• Brucella suis


• B. abortus


• B. melitensis

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	14.23(USD Million)
MARKET SIZE 2024	20.5(USD Million)
MARKET SIZE 2035	65.3(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	11.107% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Allied Veterinary Products, Biocon, IDEXX Laboratories, Neogen Corporation, Vetoquinol, Agrovet Market Animal Health, Heska Corporation, Merck Animal Health, Hester Biosciences, Indian Immunologicals, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Bioniche Animal Health, Zoetis
SEGMENTS COVERED	species
KEY MARKET OPPORTUNITIES	Rising livestock population, Increased awareness programs, Improved diagnostic tools, Enhanced vaccination strategies, Government support initiatives
KEY MARKET DYNAMICS	increasing livestock population, rising zoonotic disease awareness, government vaccination programs, enhanced diagnostic capabilities, growing demand for dairy products
COUNTRIES COVERED	India